Skip to main content
main-content

Zeitschrift

Neurological Sciences

Neurological Sciences 2/2020

Sonderheft 2/2020

Supplement 2 - X National ANIRCEF Congress

Inhaltsverzeichnis ( 44 Artikel )

12.11.2020 | EDITORIAL | Sonderheft 2/2020

Headache in the development of neurosciences

25.10.2020 | KEY LECTURE | Sonderheft 2/2020

Migraine neuroscience: from experimental models to target therapy

24.08.2020 | NEUROIMAGING IN HEADACHE RESEARCH AND DIAGNOSTICS | Sonderheft 2/2020

Role of neuroimaging in headaches’ clinical management

26.08.2020 | MIGRAINE AND PRIMARY HEADACHES | Sonderheft 2/2020

Cluster headache and TACs: state of the art

08.09.2020 | MIGRAINE AND PRIMARY HEADACHES | Sonderheft 2/2020

Other primary headaches. Cough headache, nummular headache and primary exercise headache: a secondary point of view

03.09.2020 | THERAPEUTICAL SCENARIOS IN HEADACHES | Sonderheft 2/2020

Moving closer to the ideal migraine acute treatment

18.09.2020 | THERAPEUTICAL SCENARIOS IN HEADACHES | Sonderheft 2/2020

Migraine and prophylaxis

06.10.2020 | THERAPEUTICAL SCENARIOS IN HEADACHES | Sonderheft 2/2020

Primaries non-migraine headaches treatment: a review

27.08.2020 | HEADACHES AND CEREBROVASCULAR DISEASE | Sonderheft 2/2020

Headache in cervicocerebral artery dissection

06.10.2020 | HEADACHES AND CEREBROVASCULAR DISEASE | Sonderheft 2/2020

Headache in cerebral venous thrombosis

24.09.2020 | HEADACHES AND CEREBROVASCULAR DISEASE | Sonderheft 2/2020

Headache following endovascular procedures

01.10.2020 | KEY LECTURE | Sonderheft 2/2020

Headache in neurological emergency

27.08.2020 | HEADACHES IN CSF DYNAMICS DISORDERS | Sonderheft 2/2020

Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?

09.10.2020 | HEADACHES IN CSF DYNAMICS DISORDERS | Sonderheft 2/2020

Headache in spontaneous intracranial hypotension: an overview with indications for differential diagnosis in the clinical practice

26.08.2020 | KEY LECTURE | Sonderheft 2/2020 Open Access

Gender-related differences in migraine

03.09.2020 | THE SPECTRUM OF MIGRAINE COMORBIDITIES | Sonderheft 2/2020

Sleep and migraine

03.09.2020 | THE SPECTRUM OF MIGRAINE COMORBIDITIES | Sonderheft 2/2020

Migraine and rare neurological disorders

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Stress in paediatric migraine: a trigger factor?

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Appropriateness of magnetic resonance angiography in the evaluation of migraine patients

15.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Osmophobia in migraine: multifactorial investigation and population-based survey

27.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Sleep, sleep apneas, and headache in general population

27.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Erenumab efficacy in highly resistant chronic migraine: a real-life study

13.08.2020 | COVID-19 | BRIEF COMMUNICATION | Sonderheft 2/2020 Zur Zeit gratis

Effectiveness of mindfulness by smartphone, for patients with chronic migraine and medication overuse during the Covid-19 emergency

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020 Open Access

A longitudinal clinical and MRI evaluation of the treatment with erenumab

09.11.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Efficacy and safety of erenumab in the real-life setting of S. Antonio Abate Hospital’s Headache Center (Gallarate)

27.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Migraineurs’ psychological traits do not influence response to erenumab

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Mindfulness as an add-on treatment for patients with chronic migraine and medication overuse: a preliminary analysis

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Sleep, headache and sleep breathing disturbances: a polisomnographic study

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Efficacy of erenumab 70 mg in chronic migraine: Vicenza experience

27.08.2020 | COVID-19 | Brief Communication | Sonderheft 2/2020 Zur Zeit gratis

Headache relevance in outpatient activity during Covid-19 pandemic

29.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Anti-CGRP monoclonal antibodies in cluster headache: what can we learn from recent clinical trials

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

27.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Headache burden in a HIV population of sub-Saharan Africa: scope and implications from a pilot study

27.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Poor sleep quality in patients affected by migraine: a population study

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Cluster headache and risk of chronic transformation

27.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Drug withdrawal along with bridge therapy with methylprednisolone and/or diazepam for treatment of medication overuse headache: a preliminary report from the WASH-OUT study

11.09.2020 | COVID-19 | BRIEF COMMUNICATION | Sonderheft 2/2020 Zur Zeit gratis

Headache in a group of SARS-COVID-19 patients: an observational prospectical study

26.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

One year experience with erenumab: real-life data in 30 consecutive patients

28.08.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Exploring new strategy in erenumab therapy for migraine patients

08.09.2020 | BRIEF COMMUNICATION | Sonderheft 2/2020

Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study

Aktuelle Ausgaben

Neu in den Fachgebieten Neurologie und Psychiatrie